Effect of sparteine sulphate upon basal and nutrient-induced insulin and glucagon secretion in normal man.

Abstract:

:Infusion of a therapeutic dose of sparteine sulphate, increased the basal plasma insulin level and lowered plasma glucose. When an intravenous glucose tolerance test was performed with the infusion, the total insulin AUC was significantly larger than in absence of sparteine (2025 vs 1464 microU/ml X min), plasma glucose levels were lower and improved glucose utilization was observed (kg:1.55 vs 1.39%). In the presence of arginine, sparteine sulphate stimulated both beta and alpha cells, increasing both the total insulin (1907 vs 1516 microU/ml X min p less than 0.02) and total glucagon AUCs (7616 +/- 654 vs 6789 +/- 707 pg/ml X min p less than 0.01). Thus, sparteine sulphate increased both basal and nutrient-induced insulin and glucagon secretion in normal man.

journal_name

Eur J Clin Pharmacol

authors

Sgambato S,Paolisso G,Passariello N,Varricchio M,D'Onofrio F

doi

10.1007/BF00637673

subject

Has Abstract

pub_date

1987-01-01 00:00:00

pages

477-80

issue

5

eissn

0031-6970

issn

1432-1041

journal_volume

32

pub_type

杂志文章
  • Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.

    abstract::The relationship between the serum protein binding of carbamazepine (CBZ) and carbamazepine-10,11 epoxide (CBZ-E) and the concentration of alpha 1-acid glycoprotein (AAG) and albumin (HSA) was examined in 39 CBZ-treated epileptic children aged 4 months to 12 years. A significant inverse correlation was found between t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00547424

    authors: Contin M,Riva R,Albani F,Perucca E,Lamontanara G,Baruzzi A

    更新日期:1985-01-01 00:00:00

  • Impact of biological therapy on spondyloarthritis.

    abstract:PURPOSE:In this review, we focus on the clinical and radiological aspects related to the biological therapy of ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and psoriatic arthritis (PsA). METHODS:A review was carried out in the main medical databases to evaluate the available literature. RESULTS:Even if ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-014-1706-x

    authors: Maruotti N,Cantatore FP

    更新日期:2014-09-01 00:00:00

  • Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

    abstract::Bay m 1099 is a newly developed inhibitor of intestinal alpha-glucosidase. Its ability to lower postprandial plasma glucose, serum insulin and C-peptide levels in Type II diabetics has been investigated. Fifteen obese Type II diabetic patients with inadequate metabolic control during sulphonylurea treatment received a...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00607953

    authors: Schnack C,Röggla G,Luger A,Schernthaner G

    更新日期:1986-01-01 00:00:00

  • Factors influencing drug protein binding in patients with end stage renal failure.

    abstract::Investigations were undertaken to evaluate which uraemic solutes decrease drug protein binding. This was done by performing HPLC-fractionation of uraemic biological fluids and studying the effect of addition of a lyophilisate of each fraction to normal plasma containing standard quantities of radiolabelled drugs. From...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/BF01428386

    authors: Vanholder R,De Smet R,Ringoir S

    更新日期:1993-01-01 00:00:00

  • Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol.

    abstract::Factors influencing the disposition of clotiazepam in man were evaluated in a series of pharmacokinetic studies in healthy volunteers given a single 5 mg dose. Old age caused an increased volume of distribution of clotiazepam in women, and its clearance tended to be reduced in elderly men. Use of oral contraceptives, ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00546709

    authors: Ochs HR,Greenblatt DJ,Verburg-Ochs B,Harmatz JS,Grehl H

    更新日期:1984-01-01 00:00:00

  • Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.

    abstract::In a double-blind controlled trial 22 patients with mild or moderate essential hypertension were treated with nicardipine 30 mg t.d.s. and 19 patients with propranolol 80 mg t.d.s. as monotherapy for 24 weeks. Blood pressure in both groups at the end of trial was equally and significantly reduced; systolic pressure 22...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00544554

    authors: Naukkarinen VA,Karppinen K,Sarna S

    更新日期:1987-01-01 00:00:00

  • Trends in opioid analgesics consumption, Israel, 2000-2008.

    abstract:OBJECTIVE:To describe trends in opioid consumption in Israel (morphine, methadone, oxycodone, pethidine, fentanyl, buprenorphine, codeine, and dextropropoxyphene) over the 9 years, 2000-2008, and to explore explanations for changes in consumption, in amounts and the pattern. METHODS:Data for the 2000-2008 period (all ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-010-0932-0

    authors: Ponizovsky AM,Marom E,Zeldin A,Cherny NI

    更新日期:2011-02-01 00:00:00

  • Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil.

    abstract:OBJECTIVE:To compare the efficacy of activated charcoal and gastric lavage in preventing the absorption of moclobemide, temazepam, and verapamil 30 min after drug ingestion. METHODS:In this randomized cross-over study with three phases, nine healthy volunteers received a single oral dose of 150 mg moclobemide, 10 mg t...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280000139

    authors: Lapatto-Reiniluoto O,Kivistö KT,Neuvonen PJ

    更新日期:2000-07-01 00:00:00

  • Long-term clonidine effects on autonomic function in essential hypertensive man.

    abstract::Acute studies of clonidine suggest that it lowers blood pressure by central enhancement of baroreflex sensitivity coupled with diminished evidence of sympathetic outflow, but longterm clonidine data have not been conclusive. We examined effects of one month of low dose clonidine (0.4 +/- 0.15 mg/day) alone in 13 essen...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00558378

    authors: Cohen IM,O'Connor DT,Preston RA,Stone RA

    更新日期:1981-01-01 00:00:00

  • Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.

    abstract::The pharmacokinetics of ceftazidime have been investigated after single and multiple i.v. doses in 9 young healthy male volunteers and 15 elderly male patients with acute bacterial infections. All subjects had normal, age-correlated glomerular function. Distribution and elimination in young volunteers were unaffected ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00614556

    authors: Ljungberg B,Nilsson-Ehle I

    更新日期:1988-01-01 00:00:00

  • Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials.

    abstract:OBJECTIVE:The extrapolated area under the concentration-time curve (AUC0-infinity) for any drug is considered by operating guidelines as the primary parameter related to the extent of absorption in single-dose bioavailability and bioequivalence trials. Not more than 20% should be added to the experimental AUC (AUC0-t) ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050684

    authors: Marzo A,Monti NC,Vuksic D

    更新日期:1999-11-01 00:00:00

  • The pharmacokinetics of vancomycin in patients with severe acute pancreatitis.

    abstract:OBJECTIVE:The aim of this study was to evaluate the pharmacokinetics of vancomycin in patients with severe acute pancreatitis (SAP). METHODS:Sixty-seven patients with SAP were included. The FPIA method was used to measure vancomycin serum trough concentrations, and the pharmacokinetic parameters were calculated using ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-016-2018-0

    authors: He J,Mao EQ,Feng J,Jiang HT,Yang WH,Chen EZ

    更新日期:2016-06-01 00:00:00

  • Absorption and metabolism in man of 16-epi-gitoxin, a new semi-synthetic cardioactive glycoside.

    abstract::The pharmacokinetics of 3H-16-epi-gitoxin have been investigated after oral administration: The peak serum level occurred after 30-60 min, and its subsequent decline was in two phases with half-lives of 3.5 and 19.5 h, respectively. Within 3 days 66-70% of the administered radioactivity were eliminated by renal excret...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562938

    authors: Haustein KO

    更新日期:1977-07-19 00:00:00

  • Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil.

    abstract:PURPOSE:Pharmacodynamic studies of naloxone require opioid agonism. Steady state condition may be achieved by remifentanil TCI (target controlled infusion). Opioid agonism can be measured by pupillometry. It is not known whether there are arteriovenous concentration differences for naloxone. The aim was thus to further...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-018-2545-y

    authors: Tylleskar I,Skulberg AK,Skarra S,Nilsen T,Dale O

    更新日期:2018-12-01 00:00:00

  • Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations.

    abstract:OBJECTIVE:This study was performed to investigate whether it is possible to use saliva instead of blood usually used for therapeutic drug monitoring (TDM) of disopyramide. METHODS:Six healthy male volunteers ingested 200 mg of disopyramide base, and the disopyramide concentrations in saliva and plasma (total and unbou...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s002280050250

    authors: Sagawa K,Mohri K,Shimada S,Shimizu M,Muramatsu J

    更新日期:1997-01-01 00:00:00

  • Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients.

    abstract::The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group and 9 patients give...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00265922

    authors: Kolanowski J,Younis LT,Vanbutsele R,Detry JM

    更新日期:1992-01-01 00:00:00

  • Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam.

    abstract::Eight patients were given flunitrazepam 2 mg orally, once daily for 28 consecutive days. The time-course of the plasma concentration of unchanged flunitrazepam and its principal metabolites were studied in detail after the first and last doses. Additional blood samples were collected immediately before administration ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00561899

    authors: Wickstrøm E,Amrein R,Haefelfinger P,Hartmann D

    更新日期:1980-01-01 00:00:00

  • Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

    abstract:PURPOSE:Treatment failures following vancomycin therapy in patients with methicillin-resistant Staphylococcus aureus infections have led to the utilization of higher doses of this antibiotic to achieve the trough concentrations of 10-20 μg/mL recommended by the Infectious Diseases Society of America clinical practice g...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-012-1259-9

    authors: Elyasi S,Khalili H,Dashti-Khavidaki S,Mohammadpour A

    更新日期:2012-09-01 00:00:00

  • Absorption of digoxin from the distal parts of the intestine in man.

    abstract::In 12 patients undergoing coloscopy, 0.5 mg digoxin in aqueous alcoholic solution was injected into the transverse colon. The late maximum of the blood level curve at about 2 hours after the administration suggested delayed absorption of the glycoside. However, the 24 hour urinary excretion of 17 +/- 3.4% in 8 patient...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00614003

    authors: Ochs H,Bodem G,Schäfer PK,Kodrat G,Dengler HJ

    更新日期:1975-12-19 00:00:00

  • Antagonism by domperidone of the ocular hypotensive effect of pergolide.

    abstract::1. The effect of pre-dosing with 15 mg domperidone, a relatively selective dopamine 2-receptor antagonist, on the ocular hypotensive action of a single oral dose of 25 micrograms pergolide, a dopamine 2-receptor agonist, was studied in 9 normal human volunteers, using a non-invasive method. 2. Compared with domperidon...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF02336684

    authors: al-Sereiti MR,Quik RF,Hedges A,Turner P

    更新日期:1990-01-01 00:00:00

  • The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects.

    abstract:BACKGROUND:Zolmitriptan is a 5HT(1B/1D) receptor agonist effective in the acute treatment of migraine. Clinical trials in the USA and Europe have demonstrated the optimal oral therapeutic dose to be 2.5 mg. The 2.5-mg oral tablet has recently been licensed in Japan. OBJECTIVE:To compare the pharmacokinetics of zolmitr...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s00228-002-0461-6

    authors: Yates RA,Tateno M,Nairn K,Ikegami A,Dane A,Kemp J

    更新日期:2002-07-01 00:00:00

  • Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

    abstract:PURPOSE:The aim of this study was to assess the pharmacokinetics and protein binding of cefazolin in morbidly obese patients undergoing bariatric surgery, to study the influence of bodyweight measures and age on pharmacokinetic parameters and to evaluate unbound cefazolin concentrations over time in this population. M...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-011-1048-x

    authors: van Kralingen S,Taks M,Diepstraten J,van de Garde EM,van Dongen EP,Wiezer MJ,van Ramshorst B,Vlaminckx B,Deneer VH,Knibbe CA

    更新日期:2011-10-01 00:00:00

  • The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals.

    abstract:OBJECTIVE:To describe the frequency and types of drug-related problems (DRPs) in hospitalised patients, and to identify risk factors for DRPs and the drugs most frequently causing them. METHODS:From May to December 2002, 827 patients from six internal medicine and two rheumatology departments in five hospitals in Norw...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00228-004-0830-4

    authors: Blix HS,Viktil KK,Reikvam A,Moger TA,Hjemaas BJ,Pretsch P,Vraalsen TF,Walseth EK

    更新日期:2004-11-01 00:00:00

  • Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.

    abstract:BACKGROUND AND OBJECTIVES:Dosing of vancomycin in pediatric patients undergoing continuous venous-venous hemodiafiltration (CVVHDF) is challenging. Characterization of vancomycin pharmacokinetics can assist with dosing and attainment of goal serum concentrations. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS:Patient...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-019-02664-7

    authors: Moffett BS,Morris J,Munoz F,Arikan AA

    更新日期:2019-08-01 00:00:00

  • Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.

    abstract::Eleven patients with hepatic cirrhosis or cholestasis were treated with rifampicin for 7 to 132 days. Ten patients received hexobarbital (7.32 mg/kg) and five received tolbutamide (20 mg/kg) by i.v. infusion prior to and after rifampicin treatment; plasma concentrations of the two test compounds were determined during...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00607679

    authors: Zilly W,Breimer DD,Richter E

    更新日期:1977-04-20 00:00:00

  • Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.

    abstract:PURPOSE:The aim of this study was to identify structure and language elements affecting the quality of responses from Scandinavian drug information centres (DICs). METHODS:Six different fictitious drug-related queries were sent to each of seven Scandinavian DICs. The centres were blinded for which queries were part of...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-017-2209-3

    authors: Reppe LA,Spigset O,Kampmann JP,Damkier P,Christensen HR,Böttiger Y,Schjøtt J

    更新日期:2017-05-01 00:00:00

  • Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.

    abstract:OBJECTIVE:High-density lipoprotein (HDL)-associated antioxidant paraoxonase (PON) may reduce low-density lipoprotein (LDL) oxidation and prevent atherosclerosis. The aim of this present study was to investigate the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor atorvastatin on hydroge...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-004-0820-6

    authors: Harangi M,Seres I,Varga Z,Emri G,Szilvássy Z,Paragh G,Remenyik E

    更新日期:2004-12-01 00:00:00

  • Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients.

    abstract:OBJECTIVE:Iloprost is a potent PGI2 mimetic, which has been shown to be therapeutically effective in several vascular disorders. Due to its rapid clearance from the central compartment, iloprost is administered mainly by i.v. infusion, which limits its use to hospitalized patients. In order to improve pharmacotherapeut...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s002280050336

    authors: Hildebrand M

    更新日期:1997-01-01 00:00:00

  • Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.

    abstract:PURPOSE:Although CYP3A4/5 enzymes play the predominant role in the metabolism of simvastatin and lovastatin, polymorphisms in CYP2D6 were reported to be associated with the cholesterol-lowering effect and/or tolerability of simvastatin. This study was performed to examine whether common CYP2D6 polymorphisms affect the ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-011-1202-5

    authors: Yin OQ,Mak VW,Hu M,Fok BS,Chow MS,Tomlinson B

    更新日期:2012-06-01 00:00:00

  • Prokinetic effect of AS-4370 on gastric emptying in healthy adults.

    abstract::The effect of AS-4370 on gastric emptying was investigated in healthy adults using 99mTc-DTPA. Single doses of AS-4370 2.5, 5 or 10 mg or placebo were administered to 12 subjects in a controlled, double-blind, cross-over study. Tests were performed twice weekly in each subject. Thirty min after administration of test ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00314963

    authors: Kanaizumi T,Nakano H,Matsui Y,Ishikawa H,Shimizu R,Park S,Kuriya N

    更新日期:1991-01-01 00:00:00